| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |